RESÚMENES FEBRERO 2007

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

 

STAR*D: What Have We Learned?

A. John Rush
Am J Psychiatry 164:201-204, February 2007
TEXTO GRATUITO

 

A Comparison of Medication Side Effect Reports by Panic Disorder Patients With and Without Concomitant Cognitive Behavior Therapy

Sue M. Marcus, Jack Gorman, M. Katherine Shear, David Lewin, Jose Martinez, Susan Ray, Raymond Goetz, Serge Mosovich, Lauren Gorman, David Barlow, and Scott Woods

Am J Psychiatry 164:273-275, February 2007

Psychiatric Treatment in Primary Care Patients With Anxiety Disorders: A Comparison of Care Received From Primary Care Providers and Psychiatrists

Risa B. Weisberg, Ingrid Dyck, Larry Culpepper, and Martin B. Keller

Am J Psychiatry 164:276-282, February 2007

Lithium in Breast Milk and Nursing Infants: Clinical Implications

Adele C. Viguera, D. Jeffrey Newport, James Ritchie, Zachary Stowe, Theodore Whitfield, Juliana Mogielnicki, Ross J. Baldessarini, Amanda Zurick, and Lee S. Cohen

Am J Psychiatry 164:342-345, February 2007

Relative efficacy of psychotherapy and combined therapy in the treatment of depression: A meta-analysis

Saskia M. de Maat, Jack Dekker, Robert A. Schoevers and Frans de Jonghe

European Psychiatry. Volume 22, Issue 1, January 2007, Pages 1-8

 

Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population

Bernhard T. Baune, Ina Adrian and Frank Jacobi

Journal of Psychosomatic Research. Volume 62, Issue 2, February 2007, Pages 109-118


Interferon-α-induced depressive symptoms are related to changes in the cytokine network but not to cortisol

Marieke C. Wichers, Gunter Kenis, Ger H. Koek, Geert Robaeys, Nancy A. Nicolson and Michael Maes

Journal of Psychosomatic Research. Volume 62, Issue 2, February 2007, Pages 207-214

 

Effects of a Tyramine-Enriched Meal on Blood Pressure Response in Healthy Male Volunteers Treated with Selegiline Transdermal System 6 mg/24 Hour

Lawrence F. Blob, Melvin Sharoky, Bryan J. Campbell, Eva M. Kemper, Michelle Gilmor, Chad M. VanDenBerg, and Albert J. Azzaro

CNS Spectr. 2007;12(1):25-34

TEXTO GRATUITO

 

Placebo Response and Antidepressant Response

George S. Alexopoulos, Dora Kanellopoulos, Christopher Murphy, Faith Gunning-Dixon, Richard Katz, and Moonseong Heo

Am J Geriatr Psychiatry 15:149-158, February 2007

Platelet serotonin levels support depression scores for women with postpartum depression

Elisabeth Maurer-Spurej, Cheryl Pittendreigh, Shaila Misri

J Psychiatry Neurosci 2007;32(1):23-9

TEXTO GRATUITO

 

Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population

Bernhard T. Baune, Ina Adrian, Frank Jacobi

J Psychosom Res. Volume 62, Issue 2, Pages 109-118 (February 2007)

 

Course and predictors of medically unexplained pain symptoms in the general population

Kari A. Leiknes, Arnstein Finset, Torbjørn Moum, Inger Sandanger

J Psychosom Res. Volume 62, Issue 2, Pages 119-128 (February 2007)Bottom of Form

 

Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study

Annalisa Rubino, Neil Roskell, Pat Tennis, Daniel Mines, Scott Weich, Elizabeth Andrews

BMJ  2007;334:242 (3 February)

TEXTO GRATUITO

 

The impact of CYP allelic variation on antidepressant metabolism: a review

John L Black III, Dennis J O’Kane & David A Mrazek

Expert Opinion on Drug Metabolism & Toxicology. February 2007, Vol. 3, No. 1, Pages 21-31

 

Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS)

Eva-Lotta Brakemeier, Alexander Luborzewski, Heidi Danker-Hopfe, Norbert Kathmann and Malek Bajbouj

Journal of Psychiatric Research. Volume 41, Issue 5, August 2007, Pages 395-403

 

Interactions among higher trait anxiety, sympathetic activity, and endothelial function in the elderly

Kosuke Narita, Tetsuhito Murata, Toshihiko Hamada, Tetsuya Takahashi, Masao Omori, Narufumi Suganuma, Haruyoshi Yoshida and Yuji Wada

Journal of Psychiatric Research. Volume 41, Issue 5, August 2007, Pages 418-427

 

Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study
Massimo Pasquini, Angelo Picardi, Azzurra Speca, Valerio Orlandi, Lorenzo Tarsitani Pierluigi Morosini, Isabella Cascavilla and Massimo Biondi
Clinical Practice and Epidemiology in Mental Health 2007, 3:3

TEXTO GRATUITO

 

Depression in cancer patients: A critical review
Massimo Pasquini and Massimo Biondi
Clinical Practice and Epidemiology in Mental Health 2007, 3:2

TEXTO GRATUITO

 

Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial
Taner E, Demir EY, Cosar B

Adv Ther. 2006 Nov-Dec;23(6):974-87 

Paroxetine: current status in psychiatry

Chi-Un Pae and Ashwin A Patkar

Expert Review of Neurotherapeutics. February 2007, Vol. 7, No. 2, Pages 107-120

 

Emerging treatments for major depression

Trevor R Norman and Graham D Burrows

Expert Review of Neurotherapeutics. February 2007, Vol. 7, No. 2, Pages 203-213

 

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial

Afshin Akhondzadeh Basti, Esmail Moshiri, Ahamad-Ali Noorbala, Amir-Hossein Jamshidi, Seyed Hesameddin Abbasi and Shahin Akhondzadeh

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 31, Issue 2, 30 March 2007, Pages 439-442

 

Prevalence of anxiety and depression during pregnancy in a private setting sample

Original contribution

Prevalence of anxiety and depression during pregnancy in a private setting sample

A. Faisal-Cury and P. Rossi Menezes

Archives of Women's Mental Health. Volume 10, Number 1 / February, 2007: 25-32

 

Heterogeneity among depressed outpatients considered to be in remission

Mark Zimmerman, Michael A. Posternak and Iwona Chelminski

Comprehensive Psychiatry. Volume 48, Issue 2, March-April 2007, Pages 113-117

 

Specific phobia and comorbid depression: a closer look at the National Comorbidity Survey data

Yujuan Choy, Abby J. Fyer and Renee D. Goodwin

Comprehensive Psychiatry. Volume 48, Issue 2, March-April 2007, Pages 132-136

 

The interface between borderline personality disorder and bipolar spectrum disorders

Joel Paris, John Gunderson and Igor Weinberg

Comprehensive Psychiatry. Volume 48, Issue 2, March-April 2007, Pages 145-154

 

PTSD: A problematic diagnostic category

Paul R. McHugh and Glenn Treisman

Journal of Anxiety Disorders. Volume 21, Issue 2, 2007, Pages 211-222

Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder

de Geus, Femke; Denys, Damiaan; Westenberg, Herman G.M

International Clinical Psychopharmacology. 22(2):77-84, March 2007

Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study

Cookson, John; Keck, Paul E. Jr; Ketter, Terence A; Macfadden, Wayne

International Clinical Psychopharmacology. 22(2):93-100, March 2007

Persisting Low Use of Antipsychotics in the Treatment of Major Depressive Disorder With Psychotic Features

Carmen Andreescu, Benoit H. Mulsant, Catherine Peasley-Miklus, Anthony J. Rothschild, Alastair J. Flint, Moonseong Heo, Melynda Caswell, Ellen M. Whyte, and Barnett S. Meyers, for the STOP-PD Study Group

J Clin Psychiatry 2007;68:194-200

 

Efficacy and Safety of Topiramate Monotherapy in Civilian Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Phebe Tucker, Richard P. Trautman, Dorothy B. Wyatt, Jamie Thompson; Shu-Chen Wu, Julie A. Capece, and Norman R. Rosenthal

J Clin Psychiatry 2007;68:201-206

 

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

Michael E. Thase, Sara A. Corya, Olawale Osuntokun, Michael Case, David B. Henley, Todd M. Sanger, Susan B. Watson, and Sanjay Dubé

J Clin Psychiatry 2007;68:224-236

 

A Comparison of Rates of Residual Insomnia Symptoms Following Pharmacotherapy or Cognitive-Behavioral Therapy for Major Depressive Disorder

Colleen E. Carney, Zindel V. Segal, Jack D. Edinger, and Andrew D. Krystal

J Clin Psychiatry 2007;68:254-260

 

Effect of Bupropion Extended Release on Negative Emotion Processing in Major Depressive Disorder: A Pilot Functional Magnetic Resonance Imaging Study

Brigitte Robertson, Lihong Wang, Michele T. Diaz, Marilyn Aiello, Kenneth Gersing, John Beyer, Srinivasan Mukundan, Jr., Gregory McCarthy, and P. Murali Doraiswamy

J Clin Psychiatry 2007;68:261-267

 

Preadult onset vs. adult onset of major depressive disorder: a replication study
S. Zisook, A. J. Rush, I. Lesser, S. R. Wisniewski, M. Trivedi, M. M. Husain, G. K. Balasubramani, J. E. Alpert, M. Fava
Acta Psychiatrica Scandinavica 2007; 115 (3), 196–205

Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?

Anita H Clayton

Expert Opinion on Pharmacotherapy. March 2007, Vol. 8, No. 4, Pages 457-466

 

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder

Frampton, James E; Plosker, Greg L

Drugs, Volume 67, Number 2, 2007, pp. 257-265(9)

 

The relationship between generalized anxiety disorder, depression and mortality in old age

Tjalling J. Holwerda, Robert A. Schoevers, Jack Dekker, Dorly J. H. Deeg, Cees Jonker, Aartjan T. F. Beekman

International Journal of Geriatric Psychiatry. Volume 22, Issue 3, Pages 241 - 249

 

Better Patient Persistence With Once-Daily Bupropion Compared With Twice-Daily Bupropion
Stang P, Young S, Hogue S

Am J Ther. 2007 January/February;14(1):20-24 

Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, double-blind, placebo-controlled trial

H. Woelk, K.H. Arnoldt, M. Kieser and R. Hoerr

Journal of Psychiatric Research. Volume 41, Issue 6, September 2007, Pages 472-480

 

Paroxetine treatment of compulsive hoarding

Sanjaya Saxena, Arthur L. Brody, Karron M. Maidment and Lewis R. Baxter, Jr.

Journal of Psychiatric Research. Volume 41, Issue 6, September 2007, Pages 481-487

 

Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study
Nahathai Wongpakaran, Robert van Reekum, Tinakon Wongpakaran and Diana Clarke
Annals of General Psychiatry 2007, 6:7

TEXTO GRATUITO

 

How low do we go? Is duration of a 'high' integral to the definition of bipolar disorder?
Lucy Tully, Gordon Parker
Acta Neuropsychiatrica 2007; 19 (1), 38–44

Escitalopram in the Long-Term Treatment of Major Depressive Disorder in Elderly Patients
Siegfried Kasper, Ole Michael Lemming, Hans de Swart
Neuropsychobiology 2006;54:152-159

 

Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004

Marcus Wolfsperger, Waldemar Greil, Wulf Rössler and Renate Grohmann

Journal of Affective Disorders. Volume 99, Issues 1-3, April 2007, Pages 9-17

 

Cerebrovascular risk factors and subsequent depression in older general practice patients

Jasper Nuyen, Peter M. Spreeuwenberg, Aartjan T.F. Beekman, Peter P. Groenewegen, Geertrudis A.M. van den Bos and François G. Schellevis

Journal of Affective Disorders. Volume 99, Issues 1-3, April 2007, Pages 73-81

 

BMI, sex, and antidepressant response

Arif Khan, Kelly A. Schwartz, Russell L. Kolts and Walter A. Brown

Journal of Affective Disorders. Volume 99, Issues 1-3, April 2007, Pages 101-106

 

Valproate or olanzapine add-on to lithium: An 8-week, randomized, open-label study in Italian patients with a manic relapse

Giuseppe Maina, Umberto Albert, Virginio Salvi, Michele Mancini and Filippo Bogetto

Journal of Affective Disorders. Volume 99, Issues 1-3, April 2007, Pages 247-251

 

Changes in plasma cholesterol in mood disorder patients: Does treatment make a difference?

A. Gabriel

Journal of Affective Disorders. Volume 99, Issues 1-3, April 2007, Pages 273-278

 

Trauma and defense style as response predictors of pharmacological treatment in panic patients

Letícia Kipper, Carolina Blaya, Cláudia Wachleski, Marina Dornelles, Giovanni Abrahão Salum, Elizeth Heldt and Gisele G. Manfro

European Psychiatry. Volume 22, Issue 2, March 2007, Pages 87-91

 

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial
Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J

Depress Anxiety. 2007 Feb 20; [Epub ahead of print] 

Use of Complementary and Alternative Medicine Among Women With Depression: Results of a National Survey

Ping Wu, Cordelia Fuller, Xinhua Liu, Hsin-Chien Lee, Bin Fan, Christina W. Hoven, Donald Mandell, Christine Wade, and Fredi Kronenberg

Psychiatr Serv 58:349-356, March 2007

Relationship of Depression to Death or Hospitalization in Patients With Heart Failure

Andrew Sherwood, James A. Blumenthal, Ranak Trivedi, Kristy S. Johnson, Christopher M. O’Connor, Kirkwood F. Adams, Jr, Carla Sueta Dupree, Robert A. Waugh, Daniel R. Bensimhon, Laura Gaulden, Robert H. Christenson, Gary G. Koch, Alan L. Hinderliter

Arch Intern Med. 2007;167:367-373

 

Reboxetine Combination in Treatment-resistant Depression to Selective Serotonin Reuptake Inhibitors

F. López-Muñoz, C. Álamo, G. Rubio, P. García-García, A. Pardo

Pharmacopsychiatry 2007; 40: 14-19

Escitalopram in Seasonal Affective Disorder: Results of an Open Trial

E. Pjrek, D. Winkler, J. Stastny, N. Praschak-Rieder, M. Willeit, S. Kasper

Pharmacopsychiatry 2007; 40: 20-24

Venlafaxinemirtazapine combination in the treatment of persistent depressive illness

Noel Hanna, Zaf Hamzah, Henry Omoniyi Akinpeloye, David Meagher

Journal of Psychopharmacology, Vol. 21, No. 2, 161-164 (2007)

.

Regresar a RESÚMENES FEBRERO 2007